Literature DB >> 26272046

Game, set, match for factor VIII mismatch?

Connie H Miller1.   

Abstract

In this issue of Blood, Gunasekera et al provide evidence that the high rate of factor VIII (FVIII) inhibitors seen in black hemophilia A (HA) patients is not due to a mismatch between the structure of treatment products and FVIII genotypes common in blacks.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26272046      PMCID： PMC4556233          DOI： 10.1182/blood-2015-02-625574

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  10 in total

1.  Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients.

Authors:  A Lochan; S Macaulay; W C Chen; J N Mahlangu; A Krause
Journal:  Haemophilia       Date:  2014-06-21       Impact factor: 4.287

2.  Inhibitors occur more frequently in African-American and Latino haemophiliacs.

Authors:  L M Aledort; D M Dimichele
Journal:  Haemophilia       Date:  1998-01       Impact factor: 4.287

3.  Factor VIII gene variants and inhibitor risk in African American hemophilia A patients.

Authors:  Devi Gunasekera; Ruth A Ettinger; Shelley Nakaya Fletcher; Eddie A James; Maochang Liu; John C Barrett; Janice Withycombe; Dana C Matthews; Melinda S Epstein; Richard J Hughes; Kathleen P Pratt
Journal:  Blood       Date:  2015-01-23       Impact factor: 22.113

4.  F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.

Authors:  C H Miller; J Benson; D Ellingsen; J Driggers; A Payne; F M Kelly; J M Soucie; W Craig Hooper
Journal:  Haemophilia       Date:  2011-11-21       Impact factor: 4.287

5.  A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.

Authors:  J N Lozier; P S Rosenberg; J J Goedert; I Menashe
Journal:  Haemophilia       Date:  2011-03-01       Impact factor: 4.287

6.  Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database.

Authors:  S L Carpenter; J Michael Soucie; S Sterner; R Presley
Journal:  Haemophilia       Date:  2012-01-18       Impact factor: 4.287

7.  The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Authors:  Jan Astermark; Sharyne M Donfield; Edward D Gomperts; John Schwarz; Erika D Menius; Anna Pavlova; Johannes Oldenburg; Bailey Kessing; Donna M DiMichele; Amy D Shapiro; Cheryl A Winkler; Erik Berntorp
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

8.  Inhibitors of factor VIII in black patients with hemophilia.

Authors:  Kevin R Viel; Afshin Ameri; Thomas C Abshire; Rathi V Iyer; Raymond G Watts; Charles Lutcher; Cynthia Channell; Shelley A Cole; Karl M Fernstrom; Shelley Nakaya; Carol K Kasper; Arthur R Thompson; Laura Almasy; Tom E Howard
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

9.  F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Authors:  J Schwarz; J Astermark; E D Menius; M Carrington; S M Donfield; E D Gomperts; G W Nelson; J Oldenburg; A Pavlova; A D Shapiro; C A Winkler; E Berntorp
Journal:  Haemophilia       Date:  2012-09-07       Impact factor: 4.287

10.  Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A.

Authors:  Gouri Shankar Pandey; Chen Yanover; Lisa M Miller-Jenkins; Susan Garfield; Shelley A Cole; Joanne E Curran; Eric K Moses; Natalia Rydz; Vijaya Simhadri; Chava Kimchi-Sarfaty; David Lillicrap; Kevin R Viel; Teresa M Przytycka; Glenn F Pierce; Tom E Howard; Zuben E Sauna
Journal:  Nat Med       Date:  2013-09-15       Impact factor: 53.440
  10 in total
  1 in total

1.  Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study.

Authors:  Ri J Liesner; Aby Abraham; Carmen Altisent; Mark J Belletrutti; Manuel Carcao; Manuela Carvalho; Hervé Chambost; Anthony K C Chan; Leonid Dubey; Jonathan Ducore; Michael Gattens; Paolo Gresele; Yves Gruel; Benoit Guillet; Victor Jimenez-Yuste; Lidija Kitanovski; Anna Klukowska; Sunil Lohade; Maria Elisa Mancuso; Johannes Oldenburg; Anna Pavlova; Berardino Pollio; Marianne Sigaud; Vladimir Vdovin; Kateryna Vilchevska; John K M Wu; Martina Jansen; Larisa Belyanskaya; Olaf Walter; Sigurd Knaub; Ellis J Neufeld
Journal:  Thromb Haemost       Date:  2021-02-13       Impact factor: 5.249
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.